Torbafylline
CAS No. 105102-21-4
Torbafylline ( —— )
产品货号. M36118 CAS No. 105102-21-4
Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2119 | 有现货 |
|
| 10MG | ¥3183 | 有现货 |
|
| 25MG | ¥5078 | 有现货 |
|
| 50MG | ¥7133 | 有现货 |
|
| 100MG | ¥8883 | 有现货 |
|
| 500MG | ¥17820 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥2062 | 有现货 |
|
生物学信息
-
产品名称Torbafylline
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
-
产品描述Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway, and inhibits the enhanced ubiquitin-proteasome-dependent protein hydrolysis in skeletal muscle of cancer- and sepsis-prone rats.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点PDE
-
受体PDE | PI3K | cAMP
-
研究领域——
-
适应症——
化学信息
-
CAS Number105102-21-4
-
分子量338.4
-
分子式C16H26N4O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(OCC)N1C2=C(N(C)C(=O)N(CCCCC(C)(C)O)C2=O)N=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
021-51111890
购物车()
sales@molnova.cn

